BHVN: Biohaven Ltd. Stock

by  •  • Comments Off on BHVN: Biohaven Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,790.06
Enterprise Value ($M) 3,705.67
Book Value ($M) 316.01
Book Value / Share 3.12
Price / Book 11.99
NCAV ($M) 245.98
NCAV / Share 2.43
Price / NCAV 15.41

Profitability (mra)
Return on Invested Capital (ROIC) -2.33
Return on Assets (ROA) -1.57
Return on Equity (ROE) -1.88

Liquidity (mrq)
Quick Ratio 2.89
Current Ratio 2.89

Balance Sheet (mrq) ($M)
Current Assets 440.50
Assets 510.52
Liabilities 194.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Janus Henderson Group Plc 6.60 5.51
11-12 13G/A Vanguard Group Inc 8.23 0.00
02-14 13G/A Point72 Asset Management, L.P. 3.20 -37.14
02-13 13G/A Suvretta Capital Management, Llc 5.70 18.81
01-23 13G/A State Street Corp 4.82 -15.69

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 339,548 1,199,392 28.31
2025-01-13 199,163 977,341 20.38
2025-01-10 328,447 1,412,758 23.25

(click for more detail)

Similar Companies
ANRO – Alto Neuroscience, Inc. ANVS – Annovis Bio, Inc.
BHC – Bausch Health Companies Inc. BMY – Bristol-Myers Squibb Company
EBS – Emergent BioSolutions Inc.


Financial data and stock pages provided by
Fintel.io